We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Information for patients, healthcare professionals and developers of new medicines
The Advisory Group on Military and Emergency Response Medicine (AGMERM) provides specialist advice to the Ministry of Defence on the medical aspects of defence against chemical, biological and radiological threats. AGMERM works with the Ministry of Defence .
Update about the developing role of biosimilar medicines in the NHS in England and the safe, effective and consistent use of biosimilar medicines.
How to comply with the requirements on promoting medicines to the public and to prescribers and suppliers of medicines.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
Change your protocol, update your authorisation, report safety issues, submit safety updates and complete your end-of-trial study report.
How to apply for a clinical trial including eligibility, phases, model IMPDs, costs and how to make changes to your application.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Safety leaflet on opioid medicines to help patients and their families reduce the risks of harm.
Guidance on how to license electronic cigarettes and other inhaled nicotine-containing products (NCPs) as medicines in the UK.
Information for wholesale dealer licence holders about the medicines put on the UK market for UK patients that they cannot export or hoard.
Information on herbal medicines, how to apply for a traditional herbal registration (THR), banned or restricted herbal ingredients, homeopathic medicines and fees.
Report a problem ('adverse incident') with a medical device or medicine to MHRA using the Yellow Card Scheme
Information on granted EAMS scientific opinions, including the public assessment report and treatment protocols.
How veterinary medicines can be advertised.
The medicines regulators from Australia, Canada, Singapore, Switzerland and the United Kingdom (Access Consortium) have discussed the continued need for COVID-19 medicines that are safe, effective and of high quality
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices, and information about the publication of two recent Device Safety Information pages. The article also includes information on a recent National Patient Safety Alert...
Apply for an import certificate to import a medicinal product into the UK for veterinary use.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).